transient bilateral blurry vision; This is a spontaneous report from a contactable physician.  A 67-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 11Jan2021 11:00 at single dose for COVID-19 immunization (Patient age and high risk medically).  Medical history included ongoing spastic paraplegia.  He has a genetic neurological condition, he has it is called spastic paraplegia. He does not have an onset date just that it was years ago and is still an ongoing thing at this time. He believes there is a remote family history of the same neurological condition. Patient is not diabetic. There were no concomitant medications. It was reported that the patient previously took flu vaccine on 18Nov2020, almost 2 months prior. The patient experienced transient bilateral blurry vision on 11Jan2021 11:20.  Caller is asking for recommendations regarding the 2nd dose for the patient who experienced blurriness of vision. Caller reporting a patient who received the first dose of the Vaccine yesterday (11Jan2021) and developed transient bilateral blurry vision at 11:00am, 20-30 mins after the dose. He said that it was resolved within 18-24 hrs after. He is asking if there were any reports of this in the clinical trial. It was further reported that caller is calling about the COVID vaccine. He says he was curious, he is a clinical director in (and he was calling to report or see if anyone had reported this. The patient received his first dose of the vaccine yesterday (11Jan2021) and for less than 24 hours had transient bilateral blurry vision. He says by the second day it had totally resolved. It started about 20 minutes after the first dose and resolved within 24 hours. He did not think it met criteria to report but he wondered if they would like to him report that and see if anyone had seen that at all. Event began on 11Jan2021 about 15-20 minutes after the vaccine was given and was resolved completely within 24 hours. For the dose, he believed the patient received 0.3 ml, whatever the standard dose is. He thought the Pfizer one is 0.3 ml. He says the nurses do that he just does the medical screening but he thinks the Pfizer one is 0.3 ml and (name) is 0.5 ml but he is older so he may be wrong. No further information provided. For the anatomical location of administration of Pfizer vaccine considered as suspect, he stated it was on one of the deltoids, he is not sure which. Vaccination Facility Type was outpatient clinic. There were no additional vaccines administered on same date of the Pfizer suspect, they screen for those and he has not had any other vaccines for at least 2 weeks. It was further reported that vaccine given roughly about 11 AM and the symptoms began 11:20 AM. He called the patient this morning at 9:30 AM and he said the blurry had resolved. He says he spoke with the patient's wife and she asked the patient if it was resolved and he said yes. They did not provide the caller with the time that the blurry vision resolved. Caller says he did send the patient to their in house optometrist for an exam and the exam was unremarkable by the optometrist. There were no prior vaccinations (within 4 weeks). He also wanted to know if they could advise whether or not to give the second dose. The outcome of the event was recovered on 12Jan2021.  Information on Lot/Batch number has been requested.